A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome.

J FastmanJennifer H Foss-Feig Yitzchak Frank Danielle Halpern Harony-Nicolas HC LaytonSven Sandin Paige M SiperL TangMaria Del Pilar Trelles Jessica Zweifach Joseph D Buxbaum Alexander Kolevzon

Published in: Molecular autism (2021)

Our results suggest that intranasal oxytocin is not efficacious in improving the core symptoms of ASD in children with PMS. Trial registration NCT02710084.

Keyphrases

autism spectrum disorder
young adults
study protocol
phase iii
clinical trial
attention deficit hyperactivity disorder
phase ii
case report
intellectual disability
sleep quality
randomized controlled trial
open label
physical activity